REFERENCES
Aartsma-Rus, A., & van Ommen, G. J. (2007). Antisense-mediated exon
skipping: a versatile tool with therapeutic and research applications.Rna, 13 (10), 1609-1624. doi:10.1261/rna.653607
Al-Hamed, M. H., Kurdi, W., Alsahan, N., Alabdullah, Z., Abudraz, R.,
Tulbah, M., . . . Albaqumi, M. (2016). Genetic spectrum of Saudi Arabian
patients with antenatal cystic kidney disease and ciliopathy phenotypes
using a targeted renal gene panel. J Med Genet, 53 (5), 338-347.
doi:10.1136/jmedgenet-2015-103469
Alexiev, B. A., Lin, X., Sun, C. C., & Brenner, D. S. (2006).
Meckel-Gruber syndrome: pathologic manifestations, minimal diagnostic
criteria, and differential diagnosis. Arch Pathol Lab Med,
130 (8), 1236-1238. doi:10.1043/1543-2165(2006)130[1236:Ms]2.0.Co;2
Bachmann-Gagescu, R., Dona, M., Hetterschijt, L., Tonnaer, E., Peters,
T., de Vrieze, E., . . . van Wijk, E. (2015). The Ciliopathy Protein
CC2D2A Associates with NINL and Functions in RAB8-MICAL3-Regulated
Vesicle Trafficking. PLoS Genet, 11 (10), e1005575.
doi:10.1371/journal.pgen.1005575
Bachmann-Gagescu, R., Ishak, G. E., Dempsey, J. C., Adkins, J., O’Day,
D., Phelps, I. G., . . . Doherty, D. (2012). Genotype-phenotype
correlation in CC2D2A-related Joubert syndrome reveals an association
with ventriculomegaly and seizures. J Med Genet, 49 (2), 126-137.
doi:10.1136/jmedgenet-2011-100552
Barny, I., Perrault, I., Michel, C., Goudin, N., Defoort-Dhellemmes, S.,
Ghazi, I., . . . Gerard, X. (2019). AON-Mediated Exon Skipping to Bypass
Protein Truncation in Retinal Dystrophies Due to the Recurrent CEP290
c.4723A > T Mutation. Fact or Fiction? Genes (Basel),
10 (5). doi:10.3390/genes10050368
Ben-Salem, S., Al-Shamsi, A. M., Gleeson, J. G., Ali, B. R., &
Al-Gazali, L. (2014). Mutation spectrum of Joubert syndrome and related
disorders among Arabs. Hum Genome Var, 1 , 14020.
doi:10.1038/hgv.2014.20
Ben-Salem, S., Al-Shamsi, A. M., Gleeson, J. G., Ali, B. R., &
Al-Gazali, L. (2015). Erratum: Mutation spectrum of Joubert syndrome and
related disorders among Arabs. Hum Genome Var, 2 , 15001.
doi:10.1038/hgv.2015.1
Bennett, C. F., & Swayze, E. E. (2010). RNA targeting therapeutics:
molecular mechanisms of antisense oligonucleotides as a therapeutic
platform. Annu Rev Pharmacol Toxicol, 50 , 259-293.
doi:10.1146/annurev.pharmtox.010909.105654
Braun, D. A., & Hildebrandt, F. (2017). Ciliopathies. Cold Spring
Harb Perspect Biol, 9 (3). doi:10.1101/cshperspect.a028191
Cideciyan, A. V., Jacobson, S. G., Drack, A. V., Ho, A. C., Charng, J.,
Garafalo, A. V., . . . Russell, S. R. (2019). Effect of an intravitreal
antisense oligonucleotide on vision in Leber congenital amaurosis due to
a photoreceptor cilium defect. Nat Med, 25 (2), 225-228.
doi:10.1038/s41591-018-0295-0
Comartin, D., Gupta, G. D., Fussner, E., Coyaud, E., Hasegan, M.,
Archinti, M., . . . Pelletier, L. (2013). CEP120 and SPICE1 cooperate
with CPAP in centriole elongation. Curr Biol, 23 (14), 1360-1366.
doi:10.1016/j.cub.2013.06.002
Coppieters, F., Lefever, S., Leroy, B. P., & De Baere, E. (2010).
CEP290, a gene with many faces: mutation overview and presentation of
CEP290base. Hum Mutat, 31 (10), 1097-1108. doi:10.1002/humu.21337
Daneman, R., & Prat, A. (2015). The blood-brain barrier. Cold
Spring Harb Perspect Biol, 7 (1), a020412.
doi:10.1101/cshperspect.a020412
Delous, M., Baala, L., Salomon, R., Laclef, C., Vierkotten, J., Tory,
K., . . . Saunier, S. (2007). The ciliary gene RPGRIP1L is mutated in
cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel
syndrome. Nat Genet, 39 (7), 875-881. doi:10.1038/ng2039
den Dunnen, J. T., Dalgleish, R., Maglott, D. R., Hart, R. K.,
Greenblatt, M. S., McGowan-Jordan, J., . . . Taschner, P. E. (2016).
HGVS Recommendations for the Description of Sequence Variants: 2016
Update. Hum Mutat, 37 (6), 564-569. doi:10.1002/humu.22981
Doherty, D., Parisi, M. A., Finn, L. S., Gunay-Aygun, M., Al-Mateen, M.,
Bates, D., . . . Glass, I. A. (2010). Mutations in 3 genes (MKS3, CC2D2A
and RPGRIP1L) cause COACH syndrome (Joubert syndrome with congenital
hepatic fibrosis). J Med Genet, 47 (1), 8-21.
doi:10.1136/jmg.2009.067249
Drivas, T. G., Wojno, A. P., Tucker, B. A., Stone, E. M., & Bennett, J.
(2015). Basal exon skipping and genetic pleiotropy: A predictive model
of disease pathogenesis. Sci Transl Med, 7 (291), 291ra297.
doi:10.1126/scitranslmed.aaa5370
Garanto, A., Chung, D. C., Duijkers, L., Corral-Serrano, J. C.,
Messchaert, M., Xiao, R., . . . Collin, R. W. (2016). In vitro and in
vivo rescue of aberrant splicing in CEP290-associated LCA by antisense
oligonucleotide delivery. Hum Mol Genet, 25 (12), 2552-2563.
doi:10.1093/hmg/ddw118
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015).
Pharmacokinetics, biodistribution and cell uptake of antisense
oligonucleotides. Adv Drug Deliv Rev, 87 , 46-51.
doi:10.1016/j.addr.2015.01.008
Gorden, N. T., Arts, H. H., Parisi, M. A., Coene, K. L., Letteboer, S.
J., van Beersum, S. E., . . . Doherty, D. (2008). CC2D2A is mutated in
Joubert syndrome and interacts with the ciliopathy-associated basal body
protein CEP290. Am J Hum Genet, 83 (5), 559-571.
doi:10.1016/j.ajhg.2008.10.002
Hamosh, A., Scott, A. F., Amberger, J., Valle, D., & McKusick, V. A.
(2000). Online Mendelian Inheritance in Man (OMIM). Hum Mutat,
15 (1), 57-61.
doi:10.1002/(SICI)1098-1004(200001)15:1<57::AID-HUMU12>3.0.CO;2-G
Hartill, V., Szymanska, K., Sharif, S. M., Wheway, G., & Johnson, C. A.
(2017). Meckel-Gruber Syndrome: An Update on Diagnosis, Clinical
Management, and Research Advances. Front Pediatr, 5 , 244.
doi:10.3389/fped.2017.00244
Himawan, E., Ekstrom, P., Buzgo, M., Gaillard, P., Stefansson, E.,
Marigo, V., . . . Paquet-Durand, F. (2019). Drug delivery to retinal
photoreceptors. Drug Discov Today, 24 (8), 1637-1643.
doi:10.1016/j.drudis.2019.03.004
Hopp, K., Heyer, C. M., Hommerding, C. J., Henke, S. A., Sundsbak, J.
L., Patel, S., . . . Harris, P. C. (2011). B9D1 is revealed as a novel
Meckel syndrome (MKS) gene by targeted exon-enriched next-generation
sequencing and deletion analysis. Hum Mol Genet, 20 (13),
2524-2534. doi:10.1093/hmg/ddr151
Iannicelli, M., Brancati, F., Mougou-Zerelli, S., Mazzotta, A., Thomas,
S., Elkhartoufi, N., . . . Valente, E. M. (2010). Novel TMEM67 mutations
and genotype-phenotype correlates in meckelin-related ciliopathies.Hum Mutat, 31 (5), E1319-1331. doi:10.1002/humu.21239
Janssen, M. J., Nieskens, T. T. G., Steevels, T. A. M., Caetano-Pinto,
P., den Braanker, D., Mulder, M., . . . Wilmer, M. J. (2019). Therapy
with 2’-O-Me Phosphorothioate Antisense Oligonucleotides Causes
Reversible Proteinuria by Inhibiting Renal Protein Reabsorption.Mol Ther Nucleic Acids, 18 , 298-307.
doi:10.1016/j.omtn.2019.08.025
Jones, D., Fiozzo, F., Waters, B., McKnight, D., & Brown, S. (2014).
First-trimester diagnosis of Meckel-Gruber syndrome by fetal ultrasound
with molecular identification of CC2D2A mutations by next-generation
sequencing. Ultrasound Obstet Gynecol, 44 (6), 719-721.
doi:10.1002/uog.13381
Kagan, K. O., Dufke, A., & Gembruch, U. (2017). Renal cystic disease
and associated ciliopathies. Curr Opin Obstet Gynecol, 29 (2),
85-94. doi:10.1097/GCO.0000000000000348
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alfoldi,
J., Wang, Q., . . . MacArthur, D. G. (2020). The mutational constraint
spectrum quantified from variation in 141,456 humans. Nature,
581 (7809), 434-443. doi:10.1038/s41586-020-2308-7
Kole, R., & Krieg, A. M. (2015). Exon skipping therapy for Duchenne
muscular dystrophy. Adv Drug Deliv Rev, 87 , 104-107.
doi:10.1016/j.addr.2015.05.008
Komaki, H., Nagata, T., Saito, T., Masuda, S., Takeshita, E., Sasaki,
M., . . . Takeda, S. (2018). Systemic administration of the antisense
oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with
Duchenne muscular dystrophy. Sci Transl Med, 10 (437).
doi:10.1126/scitranslmed.aan0713
Kopanos, C., Tsiolkas, V., Kouris, A., Chapple, C. E., Albarca Aguilera,
M., Meyer, R., & Massouras, A. (2019). VarSome: the human genomic
variant search engine. Bioinformatics, 35 (11), 1978-1980.
doi:10.1093/bioinformatics/bty897
Lam, Z., Albaba, S., Study, D., & Balasubramanian, M. (2020). Atypical,
milder presentation in a child with CC2D2A and KIDINS220 variants.Clin Dysmorphol, 29 (1), 10-16. doi:10.1097/MCD.0000000000000298
Lee, J. J. A., Saito, T., Duddy, W., Takeda, S., & Yokota, T. (2018).
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro
Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping
Accompanied by Rescue of Dystrophin Expression. Methods Mol Biol,
1828 , 141-150. doi:10.1007/978-1-4939-8651-4_8
Lewis, W. R., Bales, K. L., Revell, D. Z., Croyle, M. J., Engle, S. E.,
Song, C. J., . . . Yoder, B. K. (2019). Mks6 mutations reveal tissue-
and cell type-specific roles for the cilia transition zone. FASEB
J, 33 (1), 1440-1455. doi:10.1096/fj.201801149R
Mahjoub, M. R., Xie, Z., & Stearns, T. (2010). Cep120 is asymmetrically
localized to the daughter centriole and is essential for centriole
assembly. J Cell Biol, 191 (2), 331-346. doi:10.1083/jcb.201003009
Mejecase, C., Hummel, A., Mohand-Said, S., Andrieu, C., El Shamieh, S.,
Antonio, A., . . . Audo, I. (2019). Whole exome sequencing resolves
complex phenotype and identifies CC2D2A mutations underlying
non-syndromic rod-cone dystrophy. Clin Genet, 95 (2), 329-333.
doi:10.1111/cge.13453
Mitchison, H. M., & Valente, E. M. (2017). Motile and non-motile cilia
in human pathology: from function to phenotypes. J Pathol,
241 (2), 294-309. doi:10.1002/path.4843
Molinari, E., Decker, E., Mabillard, H., Tellez, J., Srivastava, S.,
Raman, S., . . . Sayer, J. A. (2018). Human urine-derived renal
epithelial cells provide insights into kidney-specific alternate
splicing variants. Eur J Hum Genet, 26 (12), 1791-1796.
doi:10.1038/s41431-018-0212-5
Molinari, E., Ramsbottom, S. A., Srivastava, S., Booth, P., Alkanderi,
S., McLafferty, S. M., . . . Sayer, J. A. (2019). Targeted exon skipping
rescues ciliary protein composition defects in Joubert syndrome patient
fibroblasts. Sci Rep, 9 (1), 10828. doi:10.1038/s41598-019-47243-z
Molinari, E., Srivastava, S., Sayer, J. A., & Ramsbottom, S. A. (2017).
From disease modelling to personalised therapy in patients with CEP290
mutations. F1000Res, 6 , 669. doi:10.12688/f1000research.11553.1
Mougou-Zerelli, S., Thomas, S., Szenker, E., Audollent, S., Elkhartoufi,
N., Babarit, C., . . . Attie-Bitach, T. (2009). CC2D2A mutations in
Meckel and Joubert syndromes indicate a genotype-phenotype correlation.Hum Mutat, 30 (11), 1574-1582. doi:10.1002/humu.21116
Nilsen, T. W., & Graveley, B. R. (2010). Expansion of the eukaryotic
proteome by alternative splicing. Nature, 463 (7280), 457-463.
doi:10.1038/nature08909
Noor, A., Windpassinger, C., Patel, M., Stachowiak, B., Mikhailov, A.,
Azam, M., . . . Ayub, M. (2008). CC2D2A, encoding a coiled-coil and C2
domain protein, causes autosomal-recessive mental retardation with
retinitis pigmentosa. Am J Hum Genet, 82 (4), 1011-1018.
doi:10.1016/j.ajhg.2008.01.021
Novarino, G., Akizu, N., & Gleeson, J. G. (2011). Modeling human
disease in humans: the ciliopathies. Cell, 147 (1), 70-79.
doi:10.1016/j.cell.2011.09.014
Oberbauer, R., Schreiner, G. F., & Meyer, T. W. (1995). Renal uptake of
an 18-mer phosphorothioate oligonucleotide. Kidney Int, 48 (4),
1226-1232. doi:10.1038/ki.1995.406
Ojeda Naharros, I., Gesemann, M., Mateos, J. M., Barmettler, G., Forbes,
A., Ziegler, U., . . . Bachmann-Gagescu, R. (2017). Loss-of-function of
the ciliopathy protein Cc2d2a disorganizes the vesicle fusion machinery
at the periciliary membrane and indirectly affects Rab8-trafficking in
zebrafish photoreceptors. PLoS Genet, 13 (12), e1007150.
doi:10.1371/journal.pgen.1007150
Otto, E. A., Ramaswami, G., Janssen, S., Chaki, M., Allen, S. J., Zhou,
W., . . . Hildebrandt, F. (2011). Mutation analysis of 18
nephronophthisis associated ciliopathy disease genes using a DNA pooling
and next generation sequencing strategy. J Med Genet, 48 (2),
105-116. doi:10.1136/jmg.2010.082552
Pan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008).
Deep surveying of alternative splicing complexity in the human
transcriptome by high-throughput sequencing. Nat Genet, 40 (12),
1413-1415. doi:10.1038/ng.259
Pardridge, W. M. (2002). Drug and gene delivery to the brain: the
vascular route. Neuron, 36 (4), 555-558.
doi:10.1016/s0896-6273(02)01054-1
Parisi, M. A. (2019). The molecular genetics of Joubert syndrome and
related ciliopathies: The challenges of genetic and phenotypic
heterogeneity. Transl Sci Rare Dis, 4 (1-2), 25-49.
doi:10.3233/TRD-190041
Pauli, S., Altmuller, J., Schroder, S., Ohlenbusch, A.,
Dreha-Kulaczewski, S., Bergmann, C., . . . Brockmann, K. (2019).
Homozygosity for the c.428delG variant in KIAA0586 in a healthy
individual: implications for molecular testing in patients with Joubert
syndrome. J Med Genet, 56 (4), 261-264.
doi:10.1136/jmedgenet-2018-105470
Radha Rama Devi, A., Naushad, S. M., & Lingappa, L. (2020). Clinical
and Molecular Diagnosis of Joubert Syndrome and Related Disorders.Pediatr Neurol, 106 , 43-49.
doi:10.1016/j.pediatrneurol.2020.01.012
Ramsbottom, S. A., Molinari, E., Srivastava, S., Silberman, F., Henry,
C., Alkanderi, S., . . . Sayer, J. A. (2018). Targeted exon skipping of
a CEP290 mutation rescues Joubert syndrome phenotypes in vitro and in a
murine model. Proc Natl Acad Sci U S A, 115 (49), 12489-12494.
doi:10.1073/pnas.1809432115
Ramsbottom, S. A., Thelwall, P. E., Wood, K. M., Clowry, G. J., Devlin,
L. A., Silbermann, F., . . . Miles, C. G. (2020). Mouse genetics reveals
Barttin as a genetic modifier of Joubert syndrome. Proc Natl Acad
Sci U S A, 117 (2), 1113-1118. doi:10.1073/pnas.1912602117
Reiter, J. F., & Leroux, M. R. (2017). Genes and molecular pathways
underpinning ciliopathies. Nat Rev Mol Cell Biol, 18 (9), 533-547.
doi:10.1038/nrm.2017.60
Romani, M., Micalizzi, A., & Valente, E. M. (2013). Joubert syndrome:
congenital cerebellar ataxia with the molar tooth. Lancet Neurol,
12 (9), 894-905. doi:10.1016/s1474-4422(13)70136-4
Roosing, S., Romani, M., Isrie, M., Rosti, R. O., Micalizzi, A., Musaev,
D., . . . Valente, E. M. (2016). Mutations in CEP120 cause Joubert
syndrome as well as complex ciliopathy phenotypes. J Med Genet,
53 (9), 608-615. doi:10.1136/jmedgenet-2016-103832
Rozet, J. M., & Gerard, X. (2015). Understanding disease pleiotropy:
From puzzle to solution. Sci Transl Med, 7 (291), 291fs224.
doi:10.1126/scitranslmed.aac6504
Schueler, M., Halbritter, J., Phelps, I. G., Braun, D. A., Otto, E. A.,
Porath, J. D., . . . Hildebrandt, F. (2016). Large-scale targeted
sequencing comparison highlights extreme genetic heterogeneity in
nephronophthisis-related ciliopathies. J Med Genet, 53 (3),
208-214. doi:10.1136/jmedgenet-2015-103304
Servais, L., Montus, M., Guiner, C. L., Ben Yaou, R., Annoussamy, M.,
Moraux, A., . . . Voit, T. (2015). Non-Ambulant Duchenne Patients
Theoretically Treatable by Exon 53 Skipping have Severe Phenotype.J Neuromuscul Dis, 2 (3), 269-279. doi:10.3233/jnd-150100
Shaheen, R., Schmidts, M., Faqeih, E., Hashem, A., Lausch, E., Holder,
I., . . . Alkuraya, F. S. (2015). A founder CEP120 mutation in Jeune
asphyxiating thoracic dystrophy expands the role of centriolar proteins
in skeletal ciliopathies. Hum Mol Genet, 24 (5), 1410-1419.
doi:10.1093/hmg/ddu555
Shaheen, R., Szymanska, K., Basu, B., Patel, N., Ewida, N., Faqeih, E.,
. . . Alkuraya, F. S. (2016). Characterizing the morbid genome of
ciliopathies. Genome Biol, 17 (1), 242.
doi:10.1186/s13059-016-1099-5
Shamseldin, H. E., Shaheen, R., Ewida, N., Bubshait, D. K., Alkuraya,
H., Almardawi, E., . . . Alkuraya, F. S. (2020). The morbid genome of
ciliopathies: an update. Genet Med . doi:10.1038/s41436-020-0761-1
Srour, M., Hamdan, F. F., Schwartzentruber, J. A., Patry, L., Ospina, L.
H., Shevell, M. I., . . . Michaud, J. L. (2012). Mutations in TMEM231
cause Joubert syndrome in French Canadians. J Med Genet, 49 (10),
636-641. doi:10.1136/jmedgenet-2012-101132
Stenson, P. D., Mort, M., Ball, E. V., Evans, K., Hayden, M., Heywood,
S., . . . Cooper, D. N. (2017). The Human Gene Mutation Database:
towards a comprehensive repository of inherited mutation data for
medical research, genetic diagnosis and next-generation sequencing
studies. Hum Genet, 136 (6), 665-677.
doi:10.1007/s00439-017-1779-6
Szymanska, K., Berry, I., Logan, C. V., Cousins, S. R., Lindsay, H.,
Jafri, H., . . . Johnson, C. A. (2012). Founder mutations and
genotype-phenotype correlations in Meckel-Gruber syndrome and associated
ciliopathies. Cilia, 1 (1), 18. doi:10.1186/2046-2530-1-18
Tabrez, S. S., Sharma, R. D., Jain, V., Siddiqui, A. A., &
Mukhopadhyay, A. (2017). Differential alternative splicing coupled to
nonsense-mediated decay of mRNA ensures dietary restriction-induced
longevity. Nat Commun, 8 (1), 306. doi:10.1038/s41467-017-00370-5
Tallila, J., Jakkula, E., Peltonen, L., Salonen, R., & Kestila, M.
(2008). Identification of CC2D2A as a Meckel syndrome gene adds an
important piece to the ciliopathy puzzle. Am J Hum Genet, 82 (6),
1361-1367. doi:10.1016/j.ajhg.2008.05.004
Tallila, J., Salonen, R., Kohlschmidt, N., Peltonen, L., & Kestila, M.
(2009). Mutation spectrum of Meckel syndrome genes: one group of
syndromes or several distinct groups? Hum Mutat, 30 (8), E813-830.
doi:10.1002/humu.21057
Tsai, J. J., Hsu, W. B., Liu, J. H., Chang, C. W., & Tang, T. K.
(2019). CEP120 interacts with C2CD3 and Talpid3 and is required for
centriole appendage assembly and ciliogenesis. Sci Rep, 9 (1),
6037. doi:10.1038/s41598-019-42577-0
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P.,
Mardinoglu, A., . . . Pontén, F. (2015). Proteomics. Tissue-based map of
the human proteome. Science, 347 (6220), 1260419.
doi:10.1126/science.1260419
Veleri, S., Manjunath, S. H., Fariss, R. N., May-Simera, H., Brooks, M.,
Foskett, T. A., . . . Swaroop, A. (2014). Ciliopathy-associated gene
Cc2d2a promotes assembly of subdistal appendages on the mother centriole
during cilia biogenesis. Nat Commun, 5 , 4207.
doi:10.1038/ncomms5207
Vilboux, T., Doherty, D. A., Glass, I. A., Parisi, M. A., Phelps, I. G.,
Cullinane, A. R., . . . Gunay-Aygun, M. (2017). Molecular genetic
findings and clinical correlations in 100 patients with Joubert syndrome
and related disorders prospectively evaluated at a single center.Genet Med, 19 (8), 875-882. doi:10.1038/gim.2016.204
Watson, C. M., Crinnion, L. A., Berry, I. R., Harrison, S. M.,
Lascelles, C., Antanaviciute, A., . . . Bonthron, D. T. (2016). Enhanced
diagnostic yield in Meckel-Gruber and Joubert syndrome through exome
sequencing supplemented with split-read mapping. BMC Med Genet,
17 , 1. doi:10.1186/s12881-015-0265-z
Williams, C. L., Li, C., Kida, K., Inglis, P. N., Mohan, S., Semenec,
L., . . . Leroux, M. R. (2011). MKS and NPHP modules cooperate to
establish basal body/transition zone membrane associations and ciliary
gate function during ciliogenesis. J Cell Biol, 192 (6),
1023-1041. doi:10.1083/jcb.201012116
Xiao, D., Lv, C., Zhang, Z., Wu, M., Zheng, X., Yang, L., . . . Chen, J.
(2017). Novel CC2D2A compound heterozygous mutations cause Joubert
syndrome. Mol Med Rep, 15 (1), 305-308. doi:10.3892/mmr.2016.6007
Xie, Z., Moy, L. Y., Sanada, K., Zhou, Y., Buchman, J. J., & Tsai, L.
H. (2007). Cep120 and TACCs control interkinetic nuclear migration and
the neural progenitor pool. Neuron, 56 (1), 79-93.
doi:10.1016/j.neuron.2007.08.026
Yates, A. D., Achuthan, P., Akanni, W., Allen, J., Allen, J.,
Alvarez-Jarreta, J., . . . Flicek, P. (2020). Ensembl 2020.Nucleic Acids Res, 48 (D1), D682-D688. doi:10.1093/nar/gkz966
Yu, R. Z., Kim, T. W., Hong, A., Watanabe, T. A., Gaus, H. J., & Geary,
R. S. (2007). Cross-species pharmacokinetic comparison from mouse to man
of a second-generation antisense oligonucleotide, ISIS 301012, targeting
human apolipoprotein B-100. Drug Metab Dispos, 35 (3), 460-468.
doi:10.1124/dmd.106.012401
Zhao, Q., Zhou, R., Temsamani, J., Zhang, Z., Roskey, A., & Agrawal, S.
(1998). Cellular distribution of phosphorothioate oligonucleotide
following intravenous administration in mice. Antisense Nucleic
Acid Drug Dev, 8 (6), 451-458. doi:10.1089/oli.1.1998.8.451
Zhou, X., Edmonson, M. N., Wilkinson, M. R., Patel, A., Wu, G., Liu, Y.,
. . . Zhang, J. (2016). Exploring genomic alteration in pediatric cancer
using ProteinPaint. Nat Genet, 48 (1), 4-6. doi:10.1038/ng.3466